Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    7938162 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation
Conditions: Allergic Rhinitis;   Tachyphylaxis;   Rhinitis Medicamentosa
Interventions: Drug: Oxymetazoline 0.05% w/v;   Drug: Fluticasone propionate 50 micrograms per actuation;   Drug: Prazosin hydrochloride;   Drug: Placebo to Prazosin

Indicates status has not been verified in more than two years